OnKure Net Income From Continuing Ops vs Reconciled Depreciation Analysis
| OKUR Stock | 8.38 0.33 4.10% |
OnKure Therapeutics, financial indicator trend analysis is much more than just breaking down OnKure Therapeutics, prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether OnKure Therapeutics, is a good investment. Please check the relationship between OnKure Therapeutics, Net Income From Continuing Ops and its Reconciled Depreciation accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OnKure Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. To learn how to invest in OnKure Stock, please use our How to Invest in OnKure Therapeutics, guide.
Net Income From Continuing Ops vs Reconciled Depreciation
Net Income From Continuing Ops vs Reconciled Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of OnKure Therapeutics, Net Income From Continuing Ops account and Reconciled Depreciation. At this time, the significance of the direction appears to have pay attention.
The correlation between OnKure Therapeutics,'s Net Income From Continuing Ops and Reconciled Depreciation is -0.96. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of OnKure Therapeutics,, assuming nothing else is changed. The correlation between historical values of OnKure Therapeutics,'s Net Income From Continuing Ops and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of OnKure Therapeutics, are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Net Income From Continuing Ops i.e., OnKure Therapeutics,'s Net Income From Continuing Ops and Reconciled Depreciation go up and down completely randomly.
Correlation Coefficient | -0.96 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Net Income From Continuing Ops
Reconciled Depreciation
Most indicators from OnKure Therapeutics,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into OnKure Therapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OnKure Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. To learn how to invest in OnKure Stock, please use our How to Invest in OnKure Therapeutics, guide.As of 12/22/2024, Selling General Administrative is likely to drop to about 4.8 M
| 2010 | 2023 | 2024 (projected) | Interest Income | 254K | 1.6M | 1.0M | Net Interest Income | 254K | 1.6M | 1.0M |
OnKure Therapeutics, fundamental ratios Correlations
Click cells to compare fundamentals
OnKure Therapeutics, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with OnKure Therapeutics,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OnKure Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Moving against OnKure Stock
| 0.76 | EVLO | Evelo Biosciences | PairCorr |
| 0.72 | VAXX | Vaxxinity | PairCorr |
| 0.67 | FBIOP | Fortress Biotech Pref | PairCorr |
| 0.66 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.59 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to OnKure Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OnKure Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OnKure Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OnKure Therapeutics, to buy it.
The correlation of OnKure Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OnKure Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OnKure Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OnKure Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.